Champions Oncology, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Champions Oncology, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 88% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-1.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 60% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
$75Sales grew 10% in 3 years; of every extra $100 of sales, $75 became extra profit.
Higher than 76% of Healthcare companies in United States.
Asset Productivity Ratio
+10% / -21%In 3 years sales changed by +10% while total assets changed by -21%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-2.9×Operating cash was negative last year, while some debt falls due within a year.
Higher than 62% of Healthcare companies in United States.
Cash Cushion Ratio
+1%Cash, after subtracting all debt, equals 1% of its market value (net cash).
Lower than 66% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 88% of Healthcare companies in United States.
Tangible Net Worth Ratio
91%Of every $100 of net worth, $91 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 74% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Champions Oncology, Inc. made a loss over the last year. Champions Oncology, Inc. owes $0.87 for every $1 it owns. Champions Oncology, Inc. made a loss in the year to Apr 2026, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Apr 2026.
P/E ratio
LossChampions Oncology, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
17.02The share price is 17.02 times Champions Oncology, Inc.'s book value per share, higher than 92% of Healthcare companies in United States.
Market cap
$66 MThe total market value of all of Champions Oncology, Inc.'s shares at today's price (share price × number of shares), smaller than 71% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$4 MWhat Champions Oncology, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).
Book value per share
$0.28Net worth divided by the number of shares. The share price of $4.76 is 17.0 times this, which is the P/B above.
Return on equity (ROE)
-28.4%Champions Oncology, Inc. lost 28.4% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
Owes vs Owns
0.87×Champions Oncology, Inc. owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Dividend yield
NoneChampions Oncology, Inc. does not currently pay a dividend.
Revenue growth
+4%Revenue rose 4% in the year to Apr 2026, and grew 3% a year on average over 3 years.
Profit growth
LossChampions Oncology, Inc. made a loss in the year to Apr 2026, after a profit the year before.
Profit margin
-2.0%Champions Oncology, Inc. lost $2 for every $100 of revenue.
Cash vs debt
Net cashChampions Oncology, Inc. held $0 M more cash than debt (net cash) at Apr 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Champions Oncology, Inc.: $66 M ÷ $4 M (31 Jul 2026) = 17.0.
What is Champions Oncology, Inc.'s return on equity?
Champions Oncology, Inc. lost 28.4% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
How much does Champions Oncology, Inc. owe compared with what it owns?
Champions Oncology, Inc. owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Does Champions Oncology, Inc. pay a dividend?
No. Champions Oncology, Inc. does not currently pay a dividend.
Is Champions Oncology, Inc.'s revenue growing?
Revenue rose 4% in the year to Apr 2026, and grew 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.